Financials
Income statement
Fiscal date | Apr 2025 | Jan 2025 | Oct 2024 | Jul 2024 |
---|---|---|---|---|
Total reported revenue | 8.4B | 8.6B | 8.1B | 8.0B |
Cost of revenue | 3.9B | 3.8B | 3.6B | 3.7B |
Gross profit | 6.5B | 6.7B | 6.3B | 6.2B |
Operating expense | ||||
Research & development | 1.3B | 1.2B | 1.2B | 1.2B |
Selling general and admin | 3.5B | 3.6B | 3.5B | 3.4B |
Other operating expenses | — | — | — | — |
Operating income | 1.7B | 1.8B | 1.7B | 1.6B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | — | — | — | — |
Other income expense | -3.4M | -111.7M | -174.4M | -38.7M |
Pretax income | 1.7B | 1.7B | 1.5B | 1.6B |
Tax provision | 372.0M | 240.5M | 188.1M | 350.5M |
Net income | 1.3B | 1.5B | 1.3B | 1.2B |
Basic EPS | 0.1 | — | 0.1 | 0.1 |
Diluted EPS | 0.1 | — | 0.1 | 0.1 |
Basic average shares | 14.2B | — | 14.1B | 14.2B |
Diluted average shares | 14.3B | — | 14.2B | 14.4B |
EBITDA | 2.5B | 2.7B | 2.6B | 2.5B |
Net income from continuing op. | 1.3B | 1.5B | 1.3B | 1.2B |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |